← Leaderboards
William Bocik
Leidos Biomedical Research, Inc.
$34,535,363
Attributed
$34,535,363
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.9M · FY2016–25$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,535,363 · 2
By mechanism
N01$34,535,363 · 2
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Mathangi Thiagarajan$37,695,154
- Ethan Dmitrovsky$597,515,186
- Linda Hannick$6,086,594
Others in their field
Top investigators on “Proteogenomics”
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Steven A. Carr · Massachusetts Institute Of Technology$11,855,338
- Bing Zhang · Vanderbilt University$11,084,513
- Thomas Raymond Gingeras · Affymetrix, Inc.$10,629,909
- Michael Abecassis · Northwestern University$10,490,301
- John Freymann · Leidos Biomedical Research, Inc.$8,749,308
Research focus
ProteogenomicsMalignant NeoplasmsCommunitiesMeasurementProteinsTumorInvestigational TherapiesGenomicsLaboratoriesAffinityAftercareBiomedical ResearchBiopsy SpecimenCancer BiologyBenchmarkingEarly Phase Clinical TrialCompetenceBaseComplementComplex MixturesBiologicalCore BiopsyCustomClinical Trials Network
Grant awards (12)
THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY.$2,072,543
N01 · FY2025 · CA · contact PI
THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY.$6,876,079
N01 · FY2024 · CA · contact PI
THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY.$2,120,234
N01 · FY2023 · CA · contact PI
Multi-omics Analyses and Integration of NCI-CPTAC-relevant Cancer Sample$36,460
N01 · FY2022 · CA · contact PI
THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY.$6,391,309
N01 · FY2021 · CA · contact PI
Antibody Production and Characterization$4,340,893
N01 · FY2019 · CA · contact PI
Lung Cancer Multiple Reaction Monitoring Project$2,176,785
N01 · FY2019 · CA · contact PI
Multi-omics Analyses and Integration of NCI-CPTAC-relevant Cancer Sample$3,026,558
N01 · FY2018 · CA · contact PI
Antibody Production and Characterization$1,077,459
N01 · FY2018 · CA · contact PI
Lung Cancer Multiple Reaction Monitoring Project$64,567
N01 · FY2018 · CA · contact PI
Lung Cancer Multiple Reaction Monitoring Project$3,187,530
N01 · FY2017 · CA · contact PI
IGF::OT::IGF OPERATION OF GOVERNMENT-OWNED CONTRACTOR-OPERATED (GOCO) R&D FACILITIES$3,164,946
N01 · FY2016 · CA · contact PI